BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2720306)

  • 1. Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists.
    Hellewell PG; Williams TJ
    Br J Pharmacol; 1989 May; 97(1):171-80. PubMed ID: 2720306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen.
    Herbert JM; Laplace MC; Bernat A; Salel V; Maffrand JP
    Eur J Pharmacol; 1992 Jun; 216(2):175-81. PubMed ID: 1397004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
    Hellewell PG; Williams TJ
    J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the mechanism of capsaicin-induced oedema in rabbit skin.
    Newbold P; Brain SD
    Br J Pharmacol; 1995 Feb; 114(3):570-7. PubMed ID: 7537589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: contribution of neutrophils and endogenous mediators.
    Teixeira MM; Fairbairn SM; Norman KE; Williams TJ; Rossi AG; Hellewell PG
    Br J Pharmacol; 1994 Dec; 113(4):1363-71. PubMed ID: 7889293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505.
    Norman KE; Williams TJ; Rossi AG
    Br J Pharmacol; 1997 Apr; 120(7):1286-93. PubMed ID: 9105704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of oedema formation induced by N-formyl-methionyl-leucyl-phenylalanine in rabbit skin.
    Hellewell PG; Yarwood H; Williams TJ
    Br J Pharmacol; 1989 May; 97(1):181-9. PubMed ID: 2497923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents.
    Merlos M; Gómez LA; Giral M; Vericat ML; García-Rafanell J; Forn J
    Br J Pharmacol; 1991 Dec; 104(4):990-4. PubMed ID: 1810607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexamethasone on neutrophil accumulation and oedema formation in rabbit skin: an investigation of site of action.
    Yarwood H; Nourshargh S; Brain S; Williams TJ
    Br J Pharmacol; 1993 Apr; 108(4):959-66. PubMed ID: 8387386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
    Brain SD; Williams TJ
    Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
    Parnham MJ; Bittner C; Lambrecht G
    Br J Pharmacol; 1989 Oct; 98(2):574-80. PubMed ID: 2819335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.
    Hellewell PG; Jose PJ; Williams TJ
    Br J Pharmacol; 1992 Dec; 107(4):1163-72. PubMed ID: 1281720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets.
    O'Donnell SR; Barnett CJ
    Br J Pharmacol; 1988 Jun; 94(2):437-42. PubMed ID: 3293683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs.
    Pretolani M; Lefort J; Vargaftig BB
    Br J Pharmacol; 1989 Jun; 97(2):433-42. PubMed ID: 2474345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.
    Rossi AG; Norman KE; Donigi-Gale D; Shoupe TS; Edwards R; Williams TJ
    Br J Pharmacol; 1992 Sep; 107(1):44-9. PubMed ID: 1330163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.
    Walsh DT; Weg VB; Williams TJ; Nourshargh S
    Br J Pharmacol; 1995 Apr; 114(7):1343-50. PubMed ID: 7541689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.